RT Journal Article
SR Electronic
T1 Updates in the management of cranial dural arteriovenous fistula
JF Stroke and Vascular Neurology
JO Stroke Vasc Neurol
FD BMJ Publishing Group Ltd
SP 50
OP 58
DO 10.1136/svn-2019-000269
VO 5
IS 1
A1 Humain Baharvahdat
A1 Yinn Cher Ooi
A1 Wi Jin Kim
A1 Ashkan Mowla
A1 Alexander L Coon
A1 Geoffrey P Colby
YR 2020
UL http://svn.bmj.com/content/5/1/50.abstract
AB Dural arteriovenous fistula (dAVF) accounts for approximately 10% of all intracranial vascular malformations. While they can be benign lesions, the presence of retrograde venous drainage and cortical venous reflux makes the natural course of these lesions aggressive high risk of haemorrhage, neurological injury and mortality. Endovascular treatment is often the first line of treatment for dAVF. Both transarterial and transvenous approaches are used to cure dAVF. The selection of treatment approach depends on the angioarchitecture of the dAVF, the location, the direction of venous flow. Surgery and, to a lesser extent, stereotactic radiosurgery are used when endovascular approaches are impossible or unsuccessful.